CEACAM5 and neoplasm: Here, we used multiple in vitro solid tumor models with various layers of complexity to validate the effectiveness of a next-generation NK-cell CAR targeting CEA, utilizing a CCR4 receptor to increase homing and migration towards the tumor tissue.